US$ 24.67
foxo4-dri senolytic 2023 2024 Frontiers Frontiers | FOXO4-DRI regulates endothelial
Description
Nephrol Dial Transplant 2001;16:7077

Potential mechanisms underlying post-COVID cognitive impairment After recovery from COVID-19, some patients experience subjective memory loss, decreased concentration, and other cognitive problems

It was introduced to the market by Lifestar Pharma Llc on July 10, 2024

The Strive exhibit also saw significant engagement, particularly regarding recent updates and ongoing dialogue on regulatory developments from the U.S
